Annual Cash & Cash Equivalents
$25.29 M
-$5.31 M-17.36%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual cash & cash equivalents is currently $25.29 million, with the most recent change of -$5.31 million (-17.36%) on 31 December 2023. During the last 3 years, it has fallen by -$193.02 million (-88.42%). PRLD annual cash & cash equivalents is now -88.42% below its all-time high of $218.31 million, reached on 31 December 2020.PRLD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$11.13 M
-$16.69 M-59.99%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly cash and cash equivalents is currently $11.13 million, with the most recent change of -$16.69 million (-59.99%) on 30 September 2024. Over the past year, it has dropped by -$4.76 million (-29.96%). PRLD quarterly cash and cash equivalents is now -96.93% below its all-time high of $362.99 million, reached on 31 March 2021.PRLD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.4% | -30.0% |
| 3 y3 years | -88.4% | -81.9% |
| 5 y5 years | +62.2% | - |
PRLD Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.4% | at low | -81.9% | at low |
| 5 y | 5 years | -88.4% | +62.2% | -96.9% | at low |
| alltime | all time | -88.4% | +62.2% | -96.9% | at low |
Prelude Therapeutics Incorporated Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.13 M(-60.0%) |
| June 2024 | - | $27.83 M(+12.6%) |
| Mar 2024 | - | $24.71 M(-2.3%) |
| Dec 2023 | $25.29 M(-17.4%) | $25.29 M(+59.1%) |
| Sept 2023 | - | $15.90 M(-39.9%) |
| June 2023 | - | $26.45 M(+45.3%) |
| Mar 2023 | - | $18.20 M(-40.5%) |
| Dec 2022 | $30.61 M | $30.61 M(-41.2%) |
| Sept 2022 | - | $52.02 M(+2.6%) |
| June 2022 | - | $50.71 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $51.63 M(+62.2%) |
| Dec 2021 | $31.83 M(-85.4%) | $31.83 M(-48.2%) |
| Sept 2021 | - | $61.42 M(-82.1%) |
| June 2021 | - | $343.12 M(-5.5%) |
| Mar 2021 | - | $362.99 M(+66.3%) |
| Dec 2020 | $218.31 M(+1056.4%) | $218.31 M(-7.0%) |
| Sept 2020 | - | $234.79 M(+690.1%) |
| June 2020 | - | $29.72 M(+57.4%) |
| Dec 2019 | $18.88 M(+21.1%) | $18.88 M |
| Dec 2018 | $15.60 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly cash and cash equivalents year-on-year change?
What is Prelude Therapeutics Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of PRLD is $25.29 M
What is the all time high annual cash & cash equivalents for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual cash & cash equivalents is $218.31 M
What is Prelude Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, PRLD annual cash & cash equivalents has changed by -$5.31 M (-17.36%)
What is Prelude Therapeutics Incorporated quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRLD is $11.13 M
What is the all time high quarterly cash and cash equivalents for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly cash and cash equivalents is $362.99 M
What is Prelude Therapeutics Incorporated quarterly cash and cash equivalents year-on-year change?
Over the past year, PRLD quarterly cash and cash equivalents has changed by -$4.76 M (-29.96%)